GRASPA Treatment for Patients With Acute Myeloblastic Leukemia

NCT01810705 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: GRASPA

Sponsor

ERYtech Pharma